Form D · Pharmaceuticals
Natrogen Therapeutics International, Inc.
New York, NY · CIK 0001344213
Offering snapshot reported Apr 2, 2010 · SEC filing
- Reported sold
- $1.44M Offering amount: $1.44M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2010 | Initial | $1,440,500 | No comparison | 12 | SEC filing |
| Apr 2, 2010 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Apr 2, 2010 | Initial | $1,400,000 | No comparison | 6 | SEC filing |
| Sep 5, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 8, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-83126
Includes the sale and issuance of 4,802 shares of Common Stock at $300 per share.
Source: Form D, filed Apr 2, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Bartlett | Director |
| Basil Hanss | Director |
| Xiaomei Liu | Executive |
| James P. Mc Carron Jr. | Director |
| Simon Mencher | Director, Executive |
| Allen Tsao | Director |
| Longgui Wang | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
315 East 68th St.
New York, NY, 10065
New York, NY, 10065